Depression and EGFR mutation status in stage IV non-small cell lung cancer.

被引:0
|
作者
Pirl, W. F.
Greer, J.
Bemis, H.
Heist, R. S.
Gallagher, E.
Sequist, L. V.
Engelman, J. A.
Traeger, L.
Lennes, I. T.
Temel, J. S.
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.9086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9086
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Timing of immunotherapy in stage IV non-small cell lung cancer.
    Komiya, Takefumi
    Zhu, Junjia
    Takamori, Shinkichi
    Greenberg, Max
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Relationship between EGFR Mutation Status and Response to Specific Chemotherapeutic Agents in Patients with Stage IV Non-Small Cell Lung Cancer
    Ernani, Vinicius
    Chatwal, Monica S.
    Kumar, Mukesh
    Zhang, Chao
    Chen, Zhengjia
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S525 - S525
  • [3] Use of chemotherapy for patients with stage IV non-small cell lung cancer.
    Waqar, Sadaf Huma
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha
    Gao, Feng
    Robinson, Cliff Grant
    Puri, Varun
    Govindan, Ramaswamy
    Morgensztern, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Correlations between the EGFR mutation status and clinicopathological features of surgically resected non-small cell lung cancer.
    Jin, Ying
    Yu, Xinmin
    Chen, Ming
    Zhang, Yiping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] EGFR mutation analysis in histologic and cytologic specimens of non-small cell lung cancer.
    Sakai, H.
    Akagi, K.
    Sudoh, J.
    Yoneda, S.
    Komagata, H.
    Kurimoto, F.
    Hommura, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [6] The role of EGFR inhibitors as adjuvant therapy for EGFR mutation positive non-small cell lung cancer.
    Xie, Peng
    Tang, Wenjie
    Li, Xiaolin
    Sun, Xindong
    Yu, Jinming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] EGFR mutation status on brain metastases from non-small cell lung cancer
    Hsu, Fred
    De Caluwe, Alex
    Anderson, David
    Nichol, Alan
    Toriumi, Ted
    Ho, Cheryl
    [J]. LUNG CANCER, 2016, 96 : 101 - 107
  • [8] EGFR mutation status in a series of Turkish non-small cell lung cancer patients
    Calibasi-Kocal, Gizem
    Amirfallah, Arsalan
    Sever, Tolga
    Unal, Olcun Umit
    Gurel, Duygu
    Oztop, Ilhan
    Ellidokuz, Hulya
    Basbinar, Yasemin
    [J]. BIOMEDICAL REPORTS, 2020, 13 (02) : 1 - 9
  • [9] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    [J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
  • [10] Stage IV non-small cell lung cancer.: Duration of chemotherapy for locally advanced non small cell lung cancers
    Vergnenegre, A.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S72 - S77